The bisecting GlcNAc in cell growth control and tumor progression

Hazuki E. Miwa, Yinghui Song, Richard Alvarez, Richard D. Cummings, Pamela Stanley

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The bisecting GlcNAc is transferred to the core mannose residue of complex or hybrid N-glycans on glycoproteins by the β1,4-N- acetylglucosaminyltransferase III (GlcNAcT-III) or MGAT3. The addition of the bisecting GlcNAc confers unique lectin recognition properties to Nglycans. Thus, LEC10 gain-of-function Chinese hamster ovary (CHO) cells selected for the acquisition of ricin resistance, carry N-glycans with a bisecting GlcNAc, which enhances the binding of the erythroagglutinin E-PHA, but reduces the binding of ricin and galectins-1, -3 and -8. The altered interaction with galactose-binding lectins suggests that the bisecting GlcNAc affects N-glycan conformation. LEC10 mutants expressing polyoma middle T antigen (PyMT) exhibit reduced growth factor signaling. Furthermore, PyMT-induced mammary tumors lacking MGAT3, progress more rapidly than tumors with the bisecting GlcNAc on N-glycans of cell surface glycoproteins. In recent years, evidence for a new paradigm of cell growth control has emerged involving regulation of cell surface residency of growth factor and cytokine receptors via interactions and cross-linking of their branched N-glycans with a lattice of galectin(s). Specific cross-linking of glycoprotein receptors in the lattice regulates their endocytosis, leading to effects on growth factor-induced signaling. This review will describe evidence that the bisecting GlcNAc of N-glycans regulates cellular signaling and tumor progression, apparently through modulating N-glycan/galectin interactions.

Original languageEnglish (US)
Pages (from-to)609-618
Number of pages10
JournalGlycoconjugate Journal
Volume29
Issue number8-9
DOIs
StatePublished - Dec 2012

Fingerprint

Cell growth
Polysaccharides
Tumors
Galectins
Growth
Neoplasms
Ricin
Viral Tumor Antigens
beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
Intercellular Signaling Peptides and Proteins
Glycoproteins
Cells
Galectin 1
Cell signaling
Galectin 3
Cytokine Receptors
Growth Factor Receptors
Membrane Glycoproteins
Mannose
Internship and Residency

Keywords

  • Bisecting GlcNAc
  • Complex N-glycans
  • Galectins
  • Glycosylation
  • Mgat3

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

The bisecting GlcNAc in cell growth control and tumor progression. / Miwa, Hazuki E.; Song, Yinghui; Alvarez, Richard; Cummings, Richard D.; Stanley, Pamela.

In: Glycoconjugate Journal, Vol. 29, No. 8-9, 12.2012, p. 609-618.

Research output: Contribution to journalArticle

Miwa, Hazuki E. ; Song, Yinghui ; Alvarez, Richard ; Cummings, Richard D. ; Stanley, Pamela. / The bisecting GlcNAc in cell growth control and tumor progression. In: Glycoconjugate Journal. 2012 ; Vol. 29, No. 8-9. pp. 609-618.
@article{aa4247751d2141379592c3dc8ec27301,
title = "The bisecting GlcNAc in cell growth control and tumor progression",
abstract = "The bisecting GlcNAc is transferred to the core mannose residue of complex or hybrid N-glycans on glycoproteins by the β1,4-N- acetylglucosaminyltransferase III (GlcNAcT-III) or MGAT3. The addition of the bisecting GlcNAc confers unique lectin recognition properties to Nglycans. Thus, LEC10 gain-of-function Chinese hamster ovary (CHO) cells selected for the acquisition of ricin resistance, carry N-glycans with a bisecting GlcNAc, which enhances the binding of the erythroagglutinin E-PHA, but reduces the binding of ricin and galectins-1, -3 and -8. The altered interaction with galactose-binding lectins suggests that the bisecting GlcNAc affects N-glycan conformation. LEC10 mutants expressing polyoma middle T antigen (PyMT) exhibit reduced growth factor signaling. Furthermore, PyMT-induced mammary tumors lacking MGAT3, progress more rapidly than tumors with the bisecting GlcNAc on N-glycans of cell surface glycoproteins. In recent years, evidence for a new paradigm of cell growth control has emerged involving regulation of cell surface residency of growth factor and cytokine receptors via interactions and cross-linking of their branched N-glycans with a lattice of galectin(s). Specific cross-linking of glycoprotein receptors in the lattice regulates their endocytosis, leading to effects on growth factor-induced signaling. This review will describe evidence that the bisecting GlcNAc of N-glycans regulates cellular signaling and tumor progression, apparently through modulating N-glycan/galectin interactions.",
keywords = "Bisecting GlcNAc, Complex N-glycans, Galectins, Glycosylation, Mgat3",
author = "Miwa, {Hazuki E.} and Yinghui Song and Richard Alvarez and Cummings, {Richard D.} and Pamela Stanley",
year = "2012",
month = "12",
doi = "10.1007/s10719-012-9373-6",
language = "English (US)",
volume = "29",
pages = "609--618",
journal = "Glycoconjugate Journal",
issn = "0282-0080",
publisher = "Springer Netherlands",
number = "8-9",

}

TY - JOUR

T1 - The bisecting GlcNAc in cell growth control and tumor progression

AU - Miwa, Hazuki E.

AU - Song, Yinghui

AU - Alvarez, Richard

AU - Cummings, Richard D.

AU - Stanley, Pamela

PY - 2012/12

Y1 - 2012/12

N2 - The bisecting GlcNAc is transferred to the core mannose residue of complex or hybrid N-glycans on glycoproteins by the β1,4-N- acetylglucosaminyltransferase III (GlcNAcT-III) or MGAT3. The addition of the bisecting GlcNAc confers unique lectin recognition properties to Nglycans. Thus, LEC10 gain-of-function Chinese hamster ovary (CHO) cells selected for the acquisition of ricin resistance, carry N-glycans with a bisecting GlcNAc, which enhances the binding of the erythroagglutinin E-PHA, but reduces the binding of ricin and galectins-1, -3 and -8. The altered interaction with galactose-binding lectins suggests that the bisecting GlcNAc affects N-glycan conformation. LEC10 mutants expressing polyoma middle T antigen (PyMT) exhibit reduced growth factor signaling. Furthermore, PyMT-induced mammary tumors lacking MGAT3, progress more rapidly than tumors with the bisecting GlcNAc on N-glycans of cell surface glycoproteins. In recent years, evidence for a new paradigm of cell growth control has emerged involving regulation of cell surface residency of growth factor and cytokine receptors via interactions and cross-linking of their branched N-glycans with a lattice of galectin(s). Specific cross-linking of glycoprotein receptors in the lattice regulates their endocytosis, leading to effects on growth factor-induced signaling. This review will describe evidence that the bisecting GlcNAc of N-glycans regulates cellular signaling and tumor progression, apparently through modulating N-glycan/galectin interactions.

AB - The bisecting GlcNAc is transferred to the core mannose residue of complex or hybrid N-glycans on glycoproteins by the β1,4-N- acetylglucosaminyltransferase III (GlcNAcT-III) or MGAT3. The addition of the bisecting GlcNAc confers unique lectin recognition properties to Nglycans. Thus, LEC10 gain-of-function Chinese hamster ovary (CHO) cells selected for the acquisition of ricin resistance, carry N-glycans with a bisecting GlcNAc, which enhances the binding of the erythroagglutinin E-PHA, but reduces the binding of ricin and galectins-1, -3 and -8. The altered interaction with galactose-binding lectins suggests that the bisecting GlcNAc affects N-glycan conformation. LEC10 mutants expressing polyoma middle T antigen (PyMT) exhibit reduced growth factor signaling. Furthermore, PyMT-induced mammary tumors lacking MGAT3, progress more rapidly than tumors with the bisecting GlcNAc on N-glycans of cell surface glycoproteins. In recent years, evidence for a new paradigm of cell growth control has emerged involving regulation of cell surface residency of growth factor and cytokine receptors via interactions and cross-linking of their branched N-glycans with a lattice of galectin(s). Specific cross-linking of glycoprotein receptors in the lattice regulates their endocytosis, leading to effects on growth factor-induced signaling. This review will describe evidence that the bisecting GlcNAc of N-glycans regulates cellular signaling and tumor progression, apparently through modulating N-glycan/galectin interactions.

KW - Bisecting GlcNAc

KW - Complex N-glycans

KW - Galectins

KW - Glycosylation

KW - Mgat3

UR - http://www.scopus.com/inward/record.url?scp=84867745540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867745540&partnerID=8YFLogxK

U2 - 10.1007/s10719-012-9373-6

DO - 10.1007/s10719-012-9373-6

M3 - Article

VL - 29

SP - 609

EP - 618

JO - Glycoconjugate Journal

JF - Glycoconjugate Journal

SN - 0282-0080

IS - 8-9

ER -